References
- Le J, Vilcek J A N. Tumor necrosis factor and interleukin-1 cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234–248
- Schmidt J A, Mizel S B, Cohen D, Green I. Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol 1982; 128: 2177–2179
- Vilcek J, Palombella V J, Henriksen-DeStefano D, et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 1986; 163: 632–643
- Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379–385
- Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989; 10: 769–773
- McClain C J, Cohen D A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349–351
- Devière J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccaride-induced production of monokines in cirrhosis. Hepatology 1990; 11: 628–634
- Gresser J, Woodcow D, Moss J, et al. Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon a/b. Am J Pathol 1987; 128: 13–18
- Poertmann B, MacSween R N M. Diseases of the intrahepatic bile ducts. Pathology of the liver, R NM MacSween, P P Anthony, P J Scheuer. Churchill Livingstone, London 1987; 424–453
- James S P, Hoofnagle J H, Strober W, Jones E A. Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 1983; 99: 500–512
- Bodenheimer H C, LaRusso N F, Thayer W R, Charland C, Staples P J, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150–154
- McFarlane I G, Wojcicka B M, Tsantoulas D C, Portman B C, Eddleston A L W F, Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis and other chronic liver diseases. Gastroenterology 1979; 76: 1333–1340
- Jones A, Selby P J, Viner C, Hobbs S, Gore M E, McElwain T J. Tumor necrosis factor, cholestatic jaundice, and chronic liver disease. Gut 1990; 31: 938–939
- Chapman R W G, Arborgh B A M, Rhodes J M, et al. Primary sclerosing cholangitis: a review of its clinical features, colangiography and hepatic histology. Gut 1980; 21: 870–877
- Sherlock S, Scheuer P J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 287: 674–678
- Pugh R N H, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R. Transection of oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–649
- Böyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 21(Suppl 97)1–5
- Greve J W, Gouma D J, Buurman W A. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 1989; 10: 454–458
- Fugger L, Morling N, Ryder L P, et al. Ncol restriction fragment length polymophism (RFLP) of the tumor necrosis factor (TNFalpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol 1989; 30: 185–189
- Kershenobich D, Rojkind M, Quiroga A, Alcocer-Varela J. Effects of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 1990; 11: 205–209
- Palmer K R, Duerden B I, Holdsworth C D. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 1980; 21: 851–854
- van Deventer S J H, Cate J W, Tytgat G N J. Intestinal entotoxemia. Gastroenterology 1988; 94: 825–831
- Camara D S, Caruana J A, Schwartz K A, Mortes M, Nolan J P. D-galactosamine liver injury: absorbtion of endotoxin and protective effect of small bowel and colon resection in rabbits (41555). Proc Soc Exp Biol Med 1983; 172: 255–259
- Lehman V, Freudenberg M A, Galanos C. Lethal toxicity of lipopolysaccaride and tumor necrosis factor in normal and D-galactosamine treated mice. J Exp Med 1987; 165: 657–663